Kyowa Kirin Co Ltd's Fiscal Year is From January To December - All Figures are in JPY, Billions.
The item "Net-Income-From-Continuing-Operations" stands at 23.14 Billion Japanese Yens for the trailing twelve months (TTM) period ending 03/31/2025, the lowest value since 12/31/2017.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -72.14 percent compared to the value the year prior.
The 1 year change in percent is -72.14.
The 3 year change in percent is -58.27.
The 5 year change in percent is -45.17.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Net Income From Continuing Operations | 905,699,262,464.00 |
![]() | Johnson & Johnson - Net Income From Continuing Operations | 486,508,953,600.00 |
![]() | AbbVie Inc - Net Income From Continuing Operations | 399,570,305,024.00 |
![]() | Roche Holding AG - Net Income From Continuing Operations | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Net Income From Continuing Operations | 280,205,508,085.11 |